CN102834379B - 作为pbr配体的三环吲哚衍生物 - Google Patents

作为pbr配体的三环吲哚衍生物 Download PDF

Info

Publication number
CN102834379B
CN102834379B CN201180016200.0A CN201180016200A CN102834379B CN 102834379 B CN102834379 B CN 102834379B CN 201180016200 A CN201180016200 A CN 201180016200A CN 102834379 B CN102834379 B CN 102834379B
Authority
CN
China
Prior art keywords
compound
formula
pet
pbr
pet tracer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180016200.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN102834379A (zh
Inventor
R.阿查纳思
S.巴拉吉
S.M.费尔韦
D.曼齐拉斯
U.莫卡帕蒂
D.奥谢亚
J.M.帕斯莫尔
B.单
W.J.特里格
H.J.瓦德斯沃思
A.M.卡达维帕兰普穆罕默德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2010/053998 external-priority patent/WO2010109007A2/en
Priority claimed from GBGB1015203.1A external-priority patent/GB201015203D0/en
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of CN102834379A publication Critical patent/CN102834379A/zh
Application granted granted Critical
Publication of CN102834379B publication Critical patent/CN102834379B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nuclear Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201180016200.0A 2010-03-26 2011-03-28 作为pbr配体的三环吲哚衍生物 Active CN102834379B (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
PCT/EP2010/053998 WO2010109007A2 (en) 2009-03-27 2010-03-26 Indole derivatives
EPPCT/EP2010/053998 2010-03-26
IN1824/DEL/2010 2010-08-02
IN1824DE2010 2010-08-02
US12/880,218 US8501153B2 (en) 2009-03-27 2010-09-13 Active enantiomer
GB1015203.1 2010-09-13
US12/880218 2010-09-13
GBGB1015203.1A GB201015203D0 (en) 2010-03-26 2010-09-13 Active enantiomer
PCT/EP2011/054744 WO2011117421A1 (en) 2010-03-26 2011-03-28 Tricyclic indole derivatives as pbr ligands

Publications (2)

Publication Number Publication Date
CN102834379A CN102834379A (zh) 2012-12-19
CN102834379B true CN102834379B (zh) 2014-12-24

Family

ID=44259848

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180016200.0A Active CN102834379B (zh) 2010-03-26 2011-03-28 作为pbr配体的三环吲哚衍生物

Country Status (15)

Country Link
EP (1) EP2552891B1 (enExample)
JP (1) JP5830519B2 (enExample)
KR (1) KR101886879B1 (enExample)
CN (1) CN102834379B (enExample)
AU (1) AU2011231508B2 (enExample)
BR (1) BR112012021579A2 (enExample)
CA (1) CA2792394C (enExample)
ES (1) ES2688574T3 (enExample)
IL (1) IL221510A (enExample)
MX (1) MX2012010954A (enExample)
NZ (1) NZ602025A (enExample)
RU (1) RU2551423C2 (enExample)
SG (1) SG183837A1 (enExample)
WO (1) WO2011117421A1 (enExample)
ZA (1) ZA201208067B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2946159B2 (ja) 1993-04-01 1999-09-06 高浜工業株式会社 瓦焼成用のスペ−サ装着装置
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
US10709798B2 (en) 2012-11-30 2020-07-14 Ge Healthcare Limited Crystallization process of tricyclic indole derivatives
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
GB201316764D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Ltd Novel compounds
EP3226884B1 (en) 2014-12-04 2021-02-17 GE Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
CN106748802B (zh) * 2016-12-26 2018-11-13 南京理工大学 一种制备含氟仲胺的方法
CN114085221B (zh) * 2021-11-29 2022-12-09 暨南大学 含氮杂环化合物、标记的含氮杂环化合物及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044751A1 (fr) * 1999-01-26 2000-08-03 Sanofi-Synthelabo DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US20110070161A1 (en) * 2009-03-27 2011-03-24 Ge Healthcare Limited Active enantiomer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599740B1 (fr) * 1986-06-05 1988-08-12 Rhone Poulenc Sante Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant
JP2005527464A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー ｓＰＬＡ２インヒビターとしてのシクロヘプタＢインドール誘導体
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
WO2008022396A1 (en) * 2006-08-24 2008-02-28 Australian Nuclear Science & Technology Organisation Fluorinated ligands for targeting peripheral benzodiazepine receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044751A1 (fr) * 1999-01-26 2000-08-03 Sanofi-Synthelabo DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US20110070161A1 (en) * 2009-03-27 2011-03-24 Ge Healthcare Limited Active enantiomer
CN102448933A (zh) * 2009-03-27 2012-05-09 通用电气健康护理有限公司 作为pbr配体的吲哚衍生物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Chemistry, Binding Affinities, and Behavioral Properties of a New Class of "Antineophobic" Mitochondrial DBI Receptor Complex (mDRC) Ligands;A.P.Kozikowski et al;《J.Med.Chem.》;19931231;第36卷(第20期);第2908-2920页 *
Design,synthesis,and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands;Taketoshi Okubo et al;《Bioorganic & Medicinal Chemistry》;20040518;第12卷;第3569-3580页 *
Isosteric replacement of the indole nucleus by benzothiophene and benzofuran in a series of indolylglyoxylylamine derivatives with partial agonist activity at the benzodiazepine receptor;F Da Settimo et al;《Eur J Med Chem》;19961231;第31卷(第12期);第951-956页 *
Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites;Taryn P. Homes et al;《Bioorganic & Medicinal Chemistry》;20060215;第14卷(第11期);第3938-3946页 *
Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET;Idriss Bennacef et al;《Bioorganic & Medicinal Chemistry》;20061231;第14卷(第22期);第7582-7591页 *

Also Published As

Publication number Publication date
MX2012010954A (es) 2012-11-23
AU2011231508A1 (en) 2012-10-04
CN102834379A (zh) 2012-12-19
KR101886879B1 (ko) 2018-08-08
RU2551423C2 (ru) 2015-05-27
ZA201208067B (en) 2014-03-26
ES2688574T3 (es) 2018-11-05
JP5830519B2 (ja) 2015-12-09
IL221510A0 (en) 2012-12-02
SG183837A1 (en) 2012-10-30
NZ602025A (en) 2014-08-29
CA2792394A1 (en) 2011-09-29
CA2792394C (en) 2018-04-24
AU2011231508B2 (en) 2014-07-31
JP2013523621A (ja) 2013-06-17
WO2011117421A1 (en) 2011-09-29
RU2012141697A (ru) 2014-05-10
EP2552891B1 (en) 2018-08-08
KR20130018711A (ko) 2013-02-25
EP2552891A1 (en) 2013-02-06
IL221510A (en) 2016-02-29
BR112012021579A2 (pt) 2019-09-24
HK1179946A1 (en) 2013-10-11

Similar Documents

Publication Publication Date Title
US8501153B2 (en) Active enantiomer
CN102834379B (zh) 作为pbr配体的三环吲哚衍生物
US9314541B2 (en) In vivo imaging method for cancer
US9168317B2 (en) In vivo imaging method of mood disorders
CN105593210B (zh) 用于体内成像的咔唑化合物
HK1179946B (en) Tricyclic indole derivatives as pbr ligands
US9220795B2 (en) Indole derivatives
HK1167393B (en) Tricyclic indole derivates as pbr ligands

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1179946

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1179946

Country of ref document: HK